YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?

Por Schultz, Nicolai A., Johansen, Julia S.
Publicado em 2010

Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer

Por Vainer, Noomi, Dehlendorff, Christian, Johansen, Julia S.
Publicado no Oncotarget (2018)

Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer

Por Schou, Jakob Vasehus, Johansen, Julia Sidenius, Nielsen, Dorte, Rossi, Simona
Publicado no Noncoding RNA (2016)

YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Purulent Meningitis

Por Østergaard, Christian, Johansen, Julia S., Benfield, Thomas, Price, Paul A., Lundgren, Jens D.
Publicado em 2002

Brain Barriers and a Subpopulation of Astroglial Progenitors of Developing Human Forebrain Are Immunostained for the Glycoprotein YKL-40

Por Bjørnbak, Camilla, Brøchner, Christian B., Larsen, Lars A., Johansen, Julia S., Møllgård, Kjeld
Publicado em 2014

Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality – a cohort study

Por Sørensen, Allan Klitgaard, Holmgaard, Dennis Back, Mygind, Lone Hagens, Johansen, Julia, Pedersen, Court
Publicado no J Inflamm (Lond) (2015)

Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trial

Por Boisen, Mogens K., Holst, Camilla B., Consalvo, Nicola, Chinot, Olivier L., Johansen, Julia S.
Publicado no Oncotarget (2017)

Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study

Por Kringelbach, Tina Marie, Glintborg, Bente, Hogdall, Estrid V, Johansen, Julia Sidenius, Hetland, Merete Lund
Publicado no BMJ Open (2018)

Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases

Por Peltonen, Reetta, Gramkow, Mathias H., Dehlendorff, Christian, Osterlund, Pia J., Johansen, Julia S., Isoniemi, Helena
Publicado no PLoS One (2020)

Antibody Directed against Human YKL-40 Increases Tumor Volume in a Human Melanoma Xenograft Model in Scid Mice

Por Salamon, Johannes, Hoffmann, Tatjana, Elies, Eva, Peldschus, Kersten, Johansen, Julia S., Lüers, Georg, Schumacher, Udo, Wicklein, Daniel
Publicado em 2014

ANGI-05 CORRELATION BETWEEN VEGF AND YKL-40 TISSUE EXPRESSION AND PLASMA LEVELS IN GLIOBLASTOMA

Por Holst, Camilla Bjørnbak, Johansen, Julia Sidenius, Lund, Eva Løbner, Møllgård, Kjeld, Hamerlik, Petra, Poulsen, Hans Skovgaard
Publicado no Neuro Oncol (2015)

YKL-40 and genetic status of CHI3L1 in a large group of asthmatics

Por Hansen, Jakob W., Thomsen, Simon F., Porsbjerg, Celeste, Rasmussen, Linda M., Harmsen, Lotte, Johansen, Julia S., Backer, Vibeke
Publicado no Eur Clin Respir J (2015)

EPID-06. IMMUNE-RELATED PLASMA BIOMARKERS IN GLIOBLASTOMA

Por Bjørnbak Holst, Camilla, Jarle Christensen, Ib, Skjoeth-Rasmussen, Jane, Skovgaard Poulsen, Hans, Hamerlik, Petra, Sidenius Johansen, Julia
Publicado no Neuro Oncol (2019)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

Por Holst, Camilla Bjørnbak, Christensen, Ib Jarle, Skjøth-Rasmussen, Jane, Hamerlik, Petra, Poulsen, Hans Skovgaard, Johansen, Julia Sidenius
Publicado no Front Oncol (2020)

Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease

Por Holmgaard, Dennis B, Mygind, Lone H, Titlestad, Ingrid L, Madsen, Hanne, Pedersen, Svend Stenvang, Johansen, Julia S, Pedersen, Court
Publicado em 2013

The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test

Por Dam Mygind, Naja, Axelsson, Anna, Ruwald, Martin H., Dalsgaard, Morten, Steffensen, Rolf, Iversen, Kasper, Johansen, Julia S., Kastrup, Jens
Publicado no Cardiovasc Endocrinol (2016)

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing

Por Demuth, Christina, Spindler, Karen-Lise Garm, Johansen, Julia S., Pallisgaard, Niels, Nielsen, Dorte, Hogdall, Estrid, Vittrup, Benny, Sorensen, Boe Sandahl
Publicado no Transl Oncol (2018)

Prognostic and predictive value of circulating DNA for hepatic arterial infusion of chemotherapy for patients with colorectal cancer liver metastases

Por Boysen, Anders K., Schou, Jakob V., Jensen, Benny V., Nielsen, Dorte, Sørensen, Brita S., Johansen, Julia S., Spindler, Karen-Lise G.
Publicado no Mol Clin Oncol (2020)

CD6 and Syntaxin Binding Protein 6 Variants and Response to Tumor Necrosis Factor Alpha Inhibitors in Danish Patients with Rheumatoid Arthritis

Por Krintel, Sophine B., Essioux, Laurent, Wool, Assaf, Johansen, Julia S., Schreiber, Ehud, Zekharya, Tomer, Akiva, Pinchas, Østergaard, Mikkel, Hetland, Merete L.
Publicado em 2012

MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability

Por Boisen, Mogens Karsbøl, Dehlendorff, Christian, Linnemann, Dorte, Schultz, Nicolai Aagaard, Jensen, Benny Vittrup, Høgdall, Estrid Vilma Solyom, Johansen, Julia Sidenius
Publicado no BMC Cancer (2015)